Navigation Links
Alzheimer's Drug Might Help Prevent Esophageal Cancer
Date:1/12/2010

Experimental med looks promising, researchers say

TUESDAY, Jan. 12 (HealthDay News) -- An experimental Alzheimer's drug may help prevent esophageal cancer, a new study shows.

The drug, DBZ, currently in clinical trials for treatment of Alzheimer's disease, is known to have side effects on the lining of the lower colon. The cells that line the colon are similar to those seen in Barrett's esophagus, a condition that can progress to esophageal cancer. Barrett's esophagus occurs when chronic heartburn damages the lining of the esophagus.

Researchers at the University of Utrecht in the Netherlands found that DBZ halted the growth of Barrett's esophagus in rats and, in some cases, eliminated the damaged esophageal tissue.

Though the findings suggest that DBZ could be an effective way to treat Barrett's esophagus and prevent esophageal cancer, the drug is still a long way from being tested in human clinical trials, the researchers said.

The study is in the January-February issue of Disease Models & Mechanisms.

More information

The U.S. National Institute of Diabetes and Digestive and Kidney Diseases has more about Barrett's esophagus.



-- Robert Preidt



SOURCE: Company of Biologists, news release, Jan. 12, 2010


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved

Page: 1

Related medicine news :

1. Alzheimers Research Target May Be a Dead End
2. Fish Oil Might Help Relieve MS
3. HIV Drug Might Fight Cancer
4. High and mighty: first common height gene identified by researchers behind obesity gene finding
5. Vitamin C Plus Fat Might Spur Cancer
6. Mathematics might save you a trip to the ER
7. Veggies Might Ward Off Age-Linked Vision Woes
8. Rating your pain from 0 to 10 might not help your doctor
9. Blood Marker Might Help Spot Early Liver Cancer
10. Hushed Genes Might Mean Higher Lung Cancer Risk
11. Mathematics might save you a trip to the ER
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... CITY, Fla. (PRWEB) , ... October 12, 2017 , ... ... cold therapy products, announced today the introduction of an innovative new design of the ... multipurpose pad so you get maximum comfort while controlling your pain while using cold ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information about the technology: , ... to enable prevention of a major side effect of chemotherapy in children. Cisplatin ... patients. For cisplatin, hearing loss is FDA listed on-label as a dose limiting ...
(Date:10/12/2017)... ... ... Leading pediatric oncology experts at Children’s National Health System will ... the International Society of Paediatric Oncology (SIOP) Oct. 12-15. Chaired by Jeffrey ... Disorders at Children’s National, and Stephen P. Hunger, M.D., Chief of the Division ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... nation's first interactive health literacy software tool, and the Cancer Patient Education Network ... cancer patient education, today announce a new strategic alliance. , As CPEN’s ...
(Date:10/12/2017)... ... October 12, 2017 , ... Farm Forward ... and other leading institutions in announcing the launch of the Leadership Circle ... way animals are raised for food. , Founding members of the Leadership Circle ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... -- AllianceRx Walgreens Prime, the combined central specialty pharmacy and ... manager Prime Therapeutics LLC (Prime), today officially began the ... of new signage at its headquarters in ... few other company-owned facilities across the country. This also ... whom will begin to see the AllianceRx Walgreens Prime ...
(Date:9/28/2017)... 2017 Cohen Veterans Bioscience and Early Signal ... wearable and home sensors for real-time monitoring of patients ... a nonprofit organization focused on disruptive health solutions for ... analytical system to record and integrate behavioral, cognitive, physiological ... ...
(Date:9/25/2017)...  EpiVax, Inc., a leader in the fields ... announced the launch of EpiVax Oncology Inc., a ... cancer vaccines. EpiVax has provided $500,000 in seed ... technologies to the new precision immunotherapy venture. Gad ... as Chief Executive Officer. Gad brings over 25 ...
Breaking Medicine Technology: